Titan Pharmaceuticals, Inc. (NASDAQ:TTNP – Get Free Report) saw a significant decrease in short interest in the month of May. As of May 15th, there was short interest totalling 9,500 shares, a decrease of 19.5% from the April 30th total of 11,800 shares. Based on an average trading volume of 6,600 shares, the short-interest ratio […]
StockNews.com assumed coverage on shares of Titan Pharmaceuticals (NASDAQ:TTNP – Free Report) in a research note released on Saturday. The firm issued a sell rating on the specialty pharmaceutical company’s stock. Titan Pharmaceuticals Price Performance TTNP opened at $6.42 on Friday. Titan Pharmaceuticals has a 1 year low of $5.00 and a 1 year high […]
StockNews.com assumed coverage on shares of Titan Pharmaceuticals (NASDAQ:TTNP – Free Report) in a report issued on Wednesday. The firm issued a sell rating on the specialty pharmaceutical company’s stock. Titan Pharmaceuticals Price Performance NASDAQ:TTNP opened at $6.88 on Wednesday. The firm has a market capitalization of $6.29 million, a price-to-earnings ratio of -0.84 and […]
Equities researchers at StockNews.com started coverage on shares of Titan Pharmaceuticals (NASDAQ:TTNP – Get Free Report) in a report released on Tuesday. The brokerage set a “sell” rating on the specialty pharmaceutical company’s stock. Titan Pharmaceuticals Price Performance Shares of TTNP stock opened at $6.97 on Tuesday. The stock has a market capitalization of $6.34 […]
StockNews.com initiated coverage on shares of Titan Pharmaceuticals (NASDAQ:TTNP – Free Report) in a research note published on Monday morning. The firm issued a sell rating on the specialty pharmaceutical company’s stock. Titan Pharmaceuticals Price Performance NASDAQ:TTNP opened at $7.10 on Monday. The firm’s 50-day moving average price is $7.34 and its 200-day moving average […]